203 related articles for article (PubMed ID: 15389724)
21. Loss of basement membrane, receptor and cytoskeletal lattices in a laminin-deficient muscular dystrophy.
Yurchenco PD; Cheng YS; Campbell K; Li S
J Cell Sci; 2004 Feb; 117(Pt 5):735-42. PubMed ID: 14734655
[TBL] [Abstract][Full Text] [Related]
22. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.
Straub V; Rafael JA; Chamberlain JS; Campbell KP
J Cell Biol; 1997 Oct; 139(2):375-85. PubMed ID: 9334342
[TBL] [Abstract][Full Text] [Related]
23. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.
Lapidos KA; Kakkar R; McNally EM
Circ Res; 2004 Apr; 94(8):1023-31. PubMed ID: 15117830
[TBL] [Abstract][Full Text] [Related]
24. EDL and soleus muscles of the C57BL6J/dy2j laminin-alpha 2-deficient dystrophic mouse are not vulnerable to eccentric contractions.
Head SI; Bakker AJ; Liangas G
Exp Physiol; 2004 Sep; 89(5):531-9. PubMed ID: 15184359
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan.
Dowling P; Lohan J; Ohlendieck K
Eur J Cell Biol; 2003 May; 82(5):222-30. PubMed ID: 12800977
[TBL] [Abstract][Full Text] [Related]
26. Voltage-gated sodium channel (SkM1) content in dystrophin-deficient muscle.
Ribaux P; Bleicher F; Couble ML; Amsellem J; Cohen SA; Berthier C; Blaineau S
Pflugers Arch; 2001 Mar; 441(6):746-55. PubMed ID: 11316257
[TBL] [Abstract][Full Text] [Related]
27. Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI.
Amthor H; Egelhof T; McKinnell I; Ladd ME; Janssen I; Weber J; Sinn H; Schrenk HH; Forsting M; Voit T; Straub V
Neuromuscul Disord; 2004 Dec; 14(12):791-6. PubMed ID: 15564034
[TBL] [Abstract][Full Text] [Related]
28. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.
Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K
FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172
[TBL] [Abstract][Full Text] [Related]
29. Induction of dystrophin-associated proteins together with nicotinic acetylcholine receptors by denervation in the absence of dystrophin in skeletal muscles of mdx mice.
Mitsui T; Kawai H; Kawajiri M; Kunishige M; Aki K; Saito S
Biochem Biophys Res Commun; 1996 Jul; 224(3):802-7. PubMed ID: 8713126
[TBL] [Abstract][Full Text] [Related]
30. Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.
Shavlakadze T; White J; Hoh JF; Rosenthal N; Grounds MD
Mol Ther; 2004 Nov; 10(5):829-43. PubMed ID: 15509501
[TBL] [Abstract][Full Text] [Related]
31. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
32. Sarcolemmal organization in skeletal muscle lacking desmin: evidence for cytokeratins associated with the membrane skeleton at costameres.
O'Neill A; Williams MW; Resneck WG; Milner DJ; Capetanaki Y; Bloch RJ
Mol Biol Cell; 2002 Jul; 13(7):2347-59. PubMed ID: 12134074
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of deltaCaMKII isoforms in skeletal muscle regeneration: Implications in dystrophic muscle disease.
Abraham ST; Shaw C
J Cell Biochem; 2006 Feb; 97(3):621-32. PubMed ID: 16215994
[TBL] [Abstract][Full Text] [Related]
34. Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization.
Stone MR; O'Neill A; Lovering RM; Strong J; Resneck WG; Reed PW; Toivola DM; Ursitti JA; Omary MB; Bloch RJ
J Cell Sci; 2007 Nov; 120(Pt 22):3999-4008. PubMed ID: 17971417
[TBL] [Abstract][Full Text] [Related]
35. Experimental challenge for the treatment of Duchenne muscular dystrophy using a vascularized free muscle graft.
Dohi D; Ikuta Y; Ishida O; Kimori K; Kuroki H
Microsurgery; 1994; 15(12):871-6. PubMed ID: 7707929
[TBL] [Abstract][Full Text] [Related]
36. Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.
Farini A; Sitzia C; Navarro C; D'Antona G; Belicchi M; Parolini D; Del Fraro G; Razini P; Bottinelli R; Meregalli M; Torrente Y
Exp Cell Res; 2012 Jun; 318(10):1160-74. PubMed ID: 22465227
[TBL] [Abstract][Full Text] [Related]
37. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.
Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y
J Pathol; 2007 Oct; 213(2):229-38. PubMed ID: 17668421
[TBL] [Abstract][Full Text] [Related]
38. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
39. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin.
Rybakova IN; Patel JR; Ervasti JM
J Cell Biol; 2000 Sep; 150(5):1209-14. PubMed ID: 10974007
[TBL] [Abstract][Full Text] [Related]
40. Merosin (laminin-2) localization in basal lamina of normal skeletal muscle fibers and changes in plasma membrane of merosin-deficient skeletal muscle fibers.
Shibuya S; Wakayama Y; Inoue M; Kojima H; Oniki H
Med Electron Microsc; 2003 Dec; 36(4):213-20. PubMed ID: 16228654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
